Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • cmorgan
    Junior Member
    • Mar 2013
    • 3

    #1

    DE analysis using mature miRNAs with different precursor sequences

    Hi,

    I have an interesting situation. I am trying to perform a DE analysis on miRNAseq data using mirDeep2 from the miRNAs_expressed_all_samples_now.csv file.

    I am interested in the DE of my mature miRNA sequences however, there are sevreal cases where my mature miRNA has a different precursor sequence, for example:

    mmu-let-7a-5p 54439.00 mmu-let-7a-1 54439.00 54439.00 5414.39
    mmu-let-7a-5p 54422.00 mmu-let-7a-2 54422.00 54422.00 5412.70

    The expression values are similar but not the same. Has anyone dealt with this before and could you give me some advice? I am confused on whether i should (i) treat these mature miRNAs with different precursors as unique expression values (ii), if should use expression values from just one of these miRNAs or (iii), if i should add the expression values from both entires of mmu-let-7a-5p to get the actual expression value.

    Thanks in advance for any assistance with this query.
  • gpcr
    Member
    • May 2010
    • 18

    #2
    mmu-let-7a-1
    chr13: 48538179-48538272
    5'-UUCACUGUGGGAUGAGGUAGUAGGUUGUAUAGUUUUAGGGUCACACCCACCACUGGGAGAUAACUAUACAAUCUACUGUCUUUCCUAAGGUGAU-3' 94

    mmu-let-7a-2
    chr9: 41536716-41536811
    5'-CUGCAUGUUCCCAGGUUGAGGUAGUAGGUUGUAUAGUUUAGAGUUACAUCAAGGGAGAUAACUGUACAGCCUCCUAGCUUUCCUUGGGACUUGCAC-3' 96


    mmu-let-7a-5p has same sequence coming from two different precursors located at different chromosome as seen above.
    Since mature sequence is same, origin of it is difficult to know; mirdeep2 tries to fit the mature sequence into both the precursors.

    My experience says that we should use mmu-let-7a-5p as only once. I follow to take only one with highest numbers for DE analysis. otherwise same count would be represented twice which skews the data.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    38 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Working...